Nuvalent, Inc.
Ticker: NUVL
| Insider | Title |
|---|---|
| Alexandra Balcom | Chief Financial Officer |
| Andrew A. F. Hack | Director |
| Anna Protopapas | Director |
| Biomedical Innovation Master Investors (cayman) I L.p. Wellington | 10% or greater ownership |
| Cameron Wheeler | Director |
| Christopher Durant Turner | Chief Medical Officer |
| Darlene Noci | Chief Development Officer |
| Deborah Ann Miller | Chief Legal Officer |
| Dwight Gary Gilliland | Director |
| Emily Conley | Director |
| Healthcare Innovations Fund, L.p. Deerfield | Director, * Director by deputization, 10% or greater ownership |
| Henry E. Pelish | Chief Scientific Officer |
| James E Flynn | Director, * Director by deputization, 10% or greater ownership |
| James Richard Porter | President and CEO, Director |
| Joseph Pearlberg | Director |
| Management Company, L.p. (series C) Deerfield | Director, * Director by deputization, 10% or greater ownership |
| Matthew Shair | Director |
| Mgmt Hif, L.p. Deerfield | Director, * Director by deputization, 10% or greater ownership |
| Mgmt Iv, L.p. Deerfield | Director, * Director by deputization, 10% or greater ownership |
| Mgmt L.p. Deerfield | Director, * Director by deputization, 10% or greater ownership |
| Michael L. Meyers | Director |
| Partners, L.p. Deerfield | Director, * Director by deputization, 10% or greater ownership |
| Private Design Fund Iv, L.p. Deerfield | Director, * Director by deputization, 10% or greater ownership |
| Robert Bowers Jackson | Director |
| Sapna Srivastava | Director |